Abstract
In cancer treatment, knowledge of reliable prognostic factors is essential when choosing therapy, especially in cancers with good treatment results, such as endometrial carcinoma. If intensified treatment is to be considered to improve the overall results, it must be possible objectively to identify well-defined high-risk groups, as such therapy usually implies increased morbidity. Likewise, it is of clinical interest to identify low-risk groups to avoid overtreatment, an important consideration in endometrial carcinoma, as many patients are more than 70 years of age and thus easily vulnerable to complications.